Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Preventing adhesions after myomectomy surgery

Official title: Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy

Run by University Hospital, Ghent · NCT05683041 · Data updated 2026-11-12

This study is testing whether a special gel used during myomectomy surgery can help prevent scar tissue from forming in women aged 18 to 45, which could improve their chances of getting pregnant later.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment30 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations1 site (Ghent)
StatusRecruiting
StartedFebruary 22, 2023
Main results expectedJanuary 2029
Study endsJanuary 2030
Registry record updatedAugust 20, 2026
Trial IDNCT05683041 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 45 with specific types of myomas scheduled for myomectomy and without pre-existing intrauterine adhesions.

Probably not a fit

Patients who are pregnant, have endometritis, or are undergoing combined operative hysteroscopy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of an intrauterine gel in preventing intrauterine adhesions following laparoscopic or laparotomic myomectomy in women aged 18 to 45 with specific types of myomas. It is a double-blind, randomized controlled pilot trial where participants will either receive the gel or a control treatment during their surgery. A follow-up hysteroscopy will be conducted three months post-surgery to assess adhesion formation. The study aims to improve fertility outcomes by reducing postoperative complications associated with myomectomy.

Why it matters

Potential benefit: If successful, this study could significantly enhance fertility prospects for women undergoing myomectomy by reducing the risk of intrauterine adhesions.

How similar studies have gone: Other studies have shown promise in using similar antiadhesion methods, but this specific approach with Hyalobarrier® gel is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age between 18 and 45 years.
* intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy.
* absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy

Exclusion Criteria:

* pregnancy.
* laparoscopic or laparotomic myomectomy in combination with an operative hysteroscopy.
* presence of endometritis.
* other antiadhesion methods

Where it's running

  • University Hospital Ghent
    Ghent, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.